WHO WE ARE
We are an experienced and passionate group of researchers and drug developers advancing CRISPR-based therapies to commercialization. Excision’s technology demonstrated significant advances in infectious disease research including for the first time, eliminating HIV from an infected animal’s genome.
MEDIA & PRESS
The Excision BioTherapeutics team includes some of the top biochemistry, chemistry and molecular biology experts with concentrations in the fields of retrovirology, virology, viral genetics, bioinformatics and advanced drug delivery.
AREAS OF FOCUS:
|Human Immunodeficiency Virus-1 Therapeutics|
|JC Virus and Progressive Multifocal Leukoencephalopathy|
|Herpes Simplex Virus 1 and 2 Therapeutics|
|Hepatitis B Virus Therapeutics|
|Advanced DNA and Biologic Delivery Systems|
WHAT PEOPLE ARE SAYING
Researchers find new ways to kick out HIV from Infected Cells
Genome Editing Cuts Out HIV
How Many People Have Been Cured of AIDS
Health: Temple University Researchers Successfully Eliminate HIV Virus in Human Cells